New imaging techniques for non-muscle invasive bladder cancer: Ready for primetime - Abstract

Treatment of non-muscle invasive bladder cancer (NMBIC) requires direct visual appreciation of the tumor.

Transurethral resection that is dependent solely on white light cystoscopy (WLC) often fails to accurately stage or completely resect NMIBC. These deficiencies of WLC are significant contributors to the high rates of recurrence and eventual progression to muscle invasive disease. This article looks at technologies that are being used in adjunct to WLC to augment the urologist's ability to identify, stage, and treat NMIBC.

Written by:
Gillespie JA, O'Donnell MA.   Are you the author?
Department of Urology, University of Iowa, 200 Hawkins Drive, 3 RCP, Iowa City, IA 52242-1089, USA.

Reference: Urol Clin North Am. 2013 May;40(2):271-9.
doi: 10.1016/j.ucl.2013.01.014


PubMed Abstract
PMID: 23540784

UroToday.com Bladder Cancer Section